Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae
- Agata Kęsik-Szeloch1,
- Zuzanna Drulis-Kawa1Email author,
- Beata Weber-Dąbrowska2,
- Jerzy Kassner1,
- Grażyna Majkowska-Skrobek1,
- Daria Augustyniak1,
- Marzanna Łusiak-Szelachowska2,
- Maciej Żaczek2,
- Andrzej Górski2, 3 and
- Andrew M Kropinski4, 5
© Kęsik-Szeloch et al.; licensee BioMed Central Ltd. 2013
Received: 23 October 2012
Accepted: 25 March 2013
Published: 28 March 2013
Members of the genus Klebsiella are among the leading microbial pathogens associated with nosocomial infection. The increased incidence of antimicrobial resistance in these species has propelled the need for alternate/combination therapeutic regimens to aid clinical treatment. Bacteriophage therapy forms one of these alternate strategies.
Electron microscopy, burst size, host range, sensitivity of phage particles to temperature, chloroform, pH, and restriction digestion of phage DNA were used to characterize Klebsiella phages.
Results and conclusions
Of the 32 isolated phages eight belonged to the family Myoviridae, eight to the Siphoviridae whilst the remaining 16 belonged to the Podoviridae. The host range of these phages was characterised against 254 clinical Enterobacteriaceae strains including multidrug resistant Klebsiella isolates producing extended-spectrum beta-lactamases (ESBLs). Based on their lytic potential, six of the phages were further characterised for burst size, physicochemical properties and sensitivity to restriction endonuclease digestion. In addition, five were fully sequenced. Multiple phage-encoded host resistance mechanisms were identified. The Siphoviridae phage genomes (KP16 and KP36) contained low numbers of host restriction sites similar to the strategy found in T7-like phages (KP32). In addition, phage KP36 encoded its own DNA adenine methyltransferase. The φKMV-like KP34 phage was sensitive to all endonucleases used in this study. Dam methylation of KP34 DNA was detected although this was in the absence of an identifiable phage encoded methyltransferase. The Myoviridae phages KP15 and KP27 both carried Dam and Dcm methyltransferase genes and other anti-restriction mechanisms elucidated in previous studies. No other anti-restriction mechanisms were found, e.g. atypical nucleotides (hmC or glucosyl hmC), although Myoviridae phage KP27 encodes an unknown anti-restriction mechanism that needs further investigation.
KeywordsBacteriophage Klebsiella spp. Multidrug resistance Restriction endonuclease patterns Myoviridae Siphoviridae Podoviridae
Bacteriophages, or phages, are viruses that infect bacteria. They are the most abundant and the most genetically diverse biological entities on Earth, with global numbers estimated at 1030 to 1032[1, 2]. These viruses are ubiquitous throughout the environment and are found in all environments that support bacterial proliferation [3, 4]. It is now realized that phages play an important role in the cycling of organic matter in the biosphere and play a significant role in bacterial diversity [5, 6]. Successful infection by lytic bacteriophages requires attachment to a susceptible host cell through specific binding to a surface epitope, injection of the phage nucleic acid, replication, virion assembly and, finally, release of infectious progeny . In the case of Gram-negative bacteria phage adsorption to specific receptors such as pili, flagella, capsules, outer membrane proteins and lipopolysaccharides has been demonstrated .
The specificity of interaction between phage tail structures and host receptor defines the host range of these viruses . Some phages have specificity at the strain level whereas some have broader host ranges and can infect multiple bacterial strains within a single species or even multiple related species . To achieve successful infection and propagation, bacteriophages need to overcome the host resistance mechanisms that target foreign DNA on entry into the bacterium. Four types of resistance mechanisms have been categorised through their mode of action and how they target the phage life cycle. These include: adsorption inhibition, blocking of DNA injection, restriction-modification (RM) and abortive infection . Arguably, the most well-studied anti-phage defence mechanism is the restriction-modification system, which is present in over 90% of sequenced bacterial genomes . There are several antirestriction mechanisms developed by bacteriophages [13, 14]: (i) counter selection against relevant restriction sites in phage genome exemplified by coliphage T7; (ii) inhibitors of host restriction enzyme – Ocr proteins of phages T7 and T3 block type I and type III of RM systems; (iii) hydrolysis of RM system cofactors – e.g. hydrolysis of S-adenosylmethionine by T3 resulting in blockage of type I and type III RM systems; (iv) co-injection of DNA and RM inhibitors – the DarA and DarB proteins of P1 block the type I RM system; (v) stimulation of host methyltransferase activity (type I system) – Ral and Lar proteins of λ-like phages; (vi) DNA modifying enzymes – acquisition of Dam and Dcm methyltransferase genes by T4-like phages; (vii) incorporation of hypermodified nucleotides into DNA – hydroxymethylcytosine (hmC) or glucosylated hydroxymethylcytosine (glucosyl hmC) in T4-like phages .
Bacteriophages have been of interest to scientists as tools to understand fundamental molecular biology processes, as vectors for horizontal gene transfer and drivers of bacterial evolution. Moreover, bacterial viruses are convenient sources of diagnostic and genetic tools and have the potential to be used as novel therapeutic agents [4, 16]. With the increased incidence of multidrug resistance in bacteria, therapeutic and preventive options have become limited. One of the possible alternatives to antibiotics is the application of bacteriophages or phage proteins. The idea/implementation of using phages as a therapeutic intervention is well known. As antimicrobial drugs entering the pharmaceutical market is limited, there is a need for novel therapeutics where phages with lytic potential and “generally regarded as safe” (GRAS) status by the FDA fall into this category. Multidrug resistant Klebsiella pneumoniae isolates carrying extended-spectrum beta-lactamases (ESBLs) encoding plasmids are becoming increasingly associated with nosocomial infection. At present the prevalence of ESBL-producing Klebsiella strains in Europe has reached 10-30% of invasive isolates . Antibiotic usage in clinical settings, and also in animal husbandry, has led to the maintenance of ESBL-encoding bacteria in the environment . It is now well documented that ESBL-producing bacteria may also have a zoonotic origin with strains isolated from poultry, a pig farm and retail meat [19–21]. The high incidence of multidrug resistant bacteria has resulted in limited efficacy of treatment with current antibiotics, and a high probability of patient colonization by resistant strains. This manuscript focuses on Klebsiella phages and their potential as alternative antimicrobials. Phages possessing a broad spectrum of activity, and belonging to all families within the Caudovirales, were isolated and characterized. The main differences detailed in this study are the viral mechanisms for resistance to host restriction systems.
Origin and isolation of bacteriophages
Water samples used as a bacteriophage source
SOMCPH/FRNAPH titre (PFU/100 ml)
Number of isolated phages (No)
Mechanical treated sewage
Communal Wastewater Treatment Plant (Stronie Śląskie, Poland)
1 × 102/3,4 × 102
2 phages (23, 31)
Biological treated sewage
Communal Wastewater Treatment Plant (Stronie Śląskie, Poland)
4 × 101/4,4 × 102
3 phages (9, 27, 36)
Irrigated fields 1 (Wrocław, Poland)
4 × 104/5 × 104
6 phages (1, 2, 4, 8, 24, 26)
Irrigated fields 2 (Wrocław, Poland)
2 × 101/4 × 101
11 phages (6, 10, 14, 15, 17, 18, 19, 20, 21, 22, 29)
Cesspool holding tank (Nieciszów, Poland)
0/2 × 101
4 phages (12, 13, 28, 34)
Roadside ditch (Nieciszów, Poland)
4 × 101/2 × 101
4 phages (5, 7, 16, 32)
Home well (Strachocin, Wrocław, Poland)
1 phage (25)
Excavation pond “Biała Marianna” Sienna (Poland)
1 phage (33)
Determination of phage host range
Bacterial strains used for determination of Klebsiella phages host range
Number of isolates
Klebsiella pneumoniae subsp. pneumoniae ESBL(+)*
Klebsiella pneumoniae subsp. pneumoniae
Clinical isolates; own collection
Klebsiella pneumoniae subsp. ozaenae
PCM 4; PCM 6**
Klebsiella pneumoniae subsp. rhinoscleromatis
PCM 2066; PCM 2067**
Clinical isolates; own collection
Klebsiella mobilis (Enterobacter aerogenes)
Clinical isolates; own collection
Clinical isolates; own collection
Pantoea (Enterobacter) agglomerans
Clinical isolate; own collection
Cronobacter (Enterobacter) sakazakii
Clinical isolate; own collection
Clinical isolates; own collection
For further detailed biological characterization six phage isolates were chosen: (i) vB_KpnM_KP15 from an irrigated field and vB_KpnM_KP27 from a communal wastewater treatment as Myoviridae representatives; (ii) vB_KpnS_KP16 from a roadside ditch and vB_KpnS_KP36 from a communal wastewater treatment as Siphoviridae representatives; (iii) vB_KpnP_KP32 from a roadside ditch and vB_KpnP_KP34 from a cesspool as Podoviridae representatives.
Lytic potential and physicochemical properties of selected bacteriophages
A high percentage (98.5-99.7%) of phages KP27, KP16, KP36, KP32 and KP34 adsorbed to K. pneumoniae cells within 5 min. By comparison, only 75% of KP15 adsorbed within this time span. The one-step growth curve indicated that the latent period for Siphoviridae and Podoviridae viruses was short (15 min) and the estimated burst size was ~50-60 phage particles per infected bacterium. The Myoviridae representatives multiplied more slowly (25 min latent period) and with lower burst size (10–15 PFU per infected cell).
The Podoviridae representatives and KP15 were shown to be relatively sensitive to high temperature, with a 100-fold decrease in titre observed after 10 min at 60°C. The concentration of PFU/ml of KP27, KP16 and KP36 was reduced by 0.5-1 orders of magnitude. With the possible exception of phage KP15, which suffered a 1.5 order decrease of virion numbers, the remainder of the phages were unaffected by chloroform. The susceptibility of KP15 (T4-like phage) to chloroform could be explained by the observation that despite the general absence of lipids, about one third of tailed phages are chloroform-sensitive .
The susceptibility to different pH conditions showed that phage particles were relatively stable within a pH range of 5–8. Incubation at pH 4 caused a 3-log decrease in phage titre of KP16 and KP34, while the other phages displayed greater stability at this pH.
Restriction analysis of phage DNA
The DNA of podovirus KP34 was sensitive to all restriction enzymes (Figure 3b, c) including DpnI, indicating DNA modification of GATC by Dam methyltransferase. Since the KP34 genome lacks a methyltransferase-encoding gene, the modification must be a result of the host enzyme .
In contrast, the second representative of the Podoviridae family, phage KP32, was highly refractory to digestion by endonucleases, including EcoRI, HindIII, DpnI, and EcoRII (Figure 3a, c). The in silico analysis revealed that the DNA lacked target sequences recognized by EcoRI and HindIII. Experimental evidence suggests that DpnI cuts the KP32 genome at one site, while in silico analysis reveals three cut sites (Webcutter 2.0) suggesting partial modification of GATC sequences as was observed with Pseudomonas aeruginosa. Only one EcoRII (CC(A/T)GG) occurs in the DNA sequence of this phage, but this enzyme requires tandem sites for effective cleavage . The difference in sensitivity to restriction endonucleases of above members of the Podoviridae provides further evidence that KP32 and KP34 belong to different genera, T7-like virus and φKMV-like virus, respectively, and use different strategies to avoid the host restriction modification (RM) defence mechanisms.
The Siphoviridae phage DNA samples (Figure 4) were sensitive to EcoRV, EcoRI, NsiI, and DpnI, and exhibited different but closely related restriction endonuclease patterns. In silico digestion of KP36 genome using Webcutter showed 302 cut sites for DpnI and 155 for EcoRII enzymes. DpnI digested KP36 DNA efficiently, but no bands were observed with EcoRII, indicating DNA modification by both Dam and Dcm methyltransferases. The genome sequence of this phage revealed the presence of a DNA adenine methyltransferase (YP_007173578; locus tag G028_gp60) and the lack of cytosine methyltransferases, which again suggested Dcm modification by host enzymes. Klebsiella pneumoniae 342 contains both DNA cytosine (YP_002237693) and DNA adenine (YP_002236240) methylases. A similarity in restriction patterns between both Siphoviridae phages (KP16 and KP36) indicates the presence of the same mechanisms of resistance to bacterial RM systems.
The agarose gel electrophoresis banding patterns obtained after restriction enzyme digestion of Myoviridae phage DNA confirmed that they were genetically different (Figure 5). KP15 DNA was resistant to digestion by several endonucleases, including HindIII, NcoI, PaeI, and EcoRII (Figure 5a, c). The in silico analysis of DNA cleavage revealed no sequences recognized by HindIII, NcoI and PaeI enzymes. The restriction resistance profiles indicated that KP15 phage DNA could have numerous modifications described in other T4-like bacteriophages. Almost total degradation of DNA by DpnI enzyme and 1148 cut sites found (Webcutter 2.0) suggested adenine methylation modification. In the case of EcoRII, 279 recognition sequences were detected in silico but no digestion was observed in gel analysis, which is evidence of Dcm methylation. Both Dam and Dcm methyltransferase genes were found in the KP15 genome.
Phage KP27 DNA was highly resistant to restriction digestion, and among the nine endonucleases tested only EcoRV showed activity (Figure 5b, c). In silico analysis showed that the DNA lacked HindIII, NcoI and PaeI sites. While the DNA contained numerous EcoRI (73), NsiI (66) and SnaBI (40) recognition sequences, it was resistant to these endonucleases. In the case of EcoRII, 276 recognition sequences were detected in silico, but no digestion was observed in gel analysis, offering evidence of Dcm methylation, which is encoded by the KP27 genome (AEX26604; locus tag KP27_137). The interesting results were obtained subsequent to attempted DpnI cleavage. While almost total degradation of DNA by DpnI enzyme was expected due to the presence of 1130 cut sites and the phage-encoded Dam methyltransferase gene, no digestion was observed. Comparing KP15 and KP27 DNA restriction patterns in silico illustrates similar sensitivity to experimental endonuclease activity and similar rates of target sites were obtained. Digestion profiles were repeated, with KP15 and KP27 phages propagated on K. oxytoca instead of K. pneumoniae. The same K. oxytoca strain was used for both phages to avoid differences in the host RM system and identical restriction patterns were obtained (data not shown). Generally, the restriction endonuclease digestion results revealed that all Klebsiella phage DNAs were sensitive to EcoRV activity regardless of genetic differences and modifications.
Discussion and conclusions
The Klebsiella bacteriophages described in recent papers belong to Podoviridae, Myoviridae and Siphoviridae families [26–30]. During this study 32 different viruses from all the aforementioned taxonomic groups were isolated and characterised. Members of the Myoviridae exhibited the broadest spectrum of lytic activity. These viruses replicated on K. pneumoniae strains but also showed lytic potential against K. oxytoca strains. No correlation was found between phage sensitivity and bacterial ESBL enzyme production. Generally, the Podoviridae and Siphoviridae viruses exhibited a narrower lytic spectrum of activity but multiplied more efficiently and elicited faster elimination of the bacterial host. The lytic efficiency of these viruses was enhanced by the production of phage-encoded soluble enzymes, including polysaccharide depolymerases illustrated as a plaque halo . Depolymerases increase antibacterial activity by disruption of the Klebsiella capsule, rendering the cells more susceptible to antibacterial agents such as other phages, antibiotics, and the immune system.
The genome sequence of phage KP36 reveals that it is a member of the Tunalikevirus genus. Since KP16 displays a restriction digestion profile very similar to that of KP36, and infects a similar number of strains, we believe that they both belong to this genus. KP36 appears to have evolved several mechanisms for evading host restriction. The low incidence of restriction sites for HindIII, NsiI, NcoI, PaeI, and SnaBI suggests counter selection of these sequences similar to the strategy of T7-like virus. Interestingly, its genome contains five sites for the type I restriction endonuclease KpnA1 (GAA(N6)TGCC) and two for KpnB1 (CAAA(N6)RTCA). Infection by coliphage T1 results in enhanced expression of adenine methyltransferase [32, 33], and increased N6-methyladenine in its genome . Since phage KP36 encodes a similar enzyme, we would expect a similar phenotype.
An example of perfect adaptation to various RM systems by loss of restriction sites is the T7-like podovirus KP32, whose DNA contains a low number of sites for all the tested restriction endonucleases. In addition, its genome contains three KpnA1 and two KpnB1 sites. Such a strategy presumably allows this virus to propagate on diverse Klebsiella strains and is a positive selectable trait for this phage group. By comparison, the second member of the Podoviridae family – the φKMV-like phage KP34 – was susceptible to all endonucleases but also exhibited Dam methylation in spite of the fact that this virus lacks its own methyltransferase gene. It is proposed that phage KP34 may use a mechanism similar to lambdoid phages to stimulate host methyltransferase activity.
The restriction resistance profiles of myoviruses KP15 and KP27 indicate that the DNA of these phages probably possesses T4-like mechanisms to overcome the RM systems of potential bacterial hosts. In silico and in vitro analyses of KP15 DNA confirmed the presence of virus-encoded Dam and Dcm methyltransferases. There was no evidence that these phages synthesized atypical nucleotides (hmC or glucosyl hmC), as indicated by the lack of dCMP hydroxymethyltransferase and glucosyltransferase genes. Surprisingly, the virus-encoded Dam methyltransferase did not efficiently modify KP27 DNA.
Phages as important tools in the elimination and clinical alleviation of Klebsiella colonization have been illustrated by the recent papers of Hung et al., Karamoddini et al. and Kumari et al.[35–39]. In selection for safe antimicrobials, the comprehensive characterization of the genome for unfavourable genes such as lysogeny-associated genes and toxins is essential alongside biological, physico-chemical and phenotype characterisation [40–42]. Characterisation of phages enables a better understanding of how their biology, including host specificity, adaptation to bacterial defence systems and propagation dynamics in natural systems, will assist in programmes to exploit bacteriophages as therapeutic agents against bacterial pathogens. In this study the phenotypic features and genetic properties of six Klebsiella phages have been examined and could be used as basic knowledge for future therapeutic work.
Materials and methods
Origin of bacteriophages
Ten clinical Klebsiella pneumoniae ESBL(+) strains plus ATCC 700603 were used as hosts for bacteriophage isolation and propagation from the eight water samples. The samples were taken from different environmental sources (Table 1). All samples were examined for faecal contamination using enteric viral pathogen assay. The Escherichia coli Famp (ATCC 700891) strain was applied as the host for male-specific (F+) coliphages (FRNAPH) and Escherichia coli B as an indicator of the somatic coliphages (SOMCPH) propagation . The bacteriophage titre in the water sample was assessed using the double-agar layer technique as according to methods described previously .
Isolation of phages
A water sample was centrifuged (15 000 × g/15 min) and the supernatant filtered through a 0.22 μm Millex-GP filter. Phage propagation followed the method of Ślopek et al.. One milliliter of filtered water sample and 0.5 ml of K. pneumoniae ESBL (+) host strain, grown overnight in Mueller Hinton Broth (MHB) (bioMérieux Polska, Warsaw, Poland) were added to 10 ml of MHB and incubated at 37°C until complete lysis appeared (approximately 4–6 h). The suspension was then filtered through a 0.22 μm Millex-GP filter. The procedure was repeated thrice to eliminate bactericidal activity of some chemical compounds present in the water samples. The bacteriophage titre in the filtrate was assessed as described above .
A high-titre phage lysate previously filtered through a 0.22 μm Millex-GP filter was centrifuged at 25 000 × g for 60 min and the pellet was washed twice in 0.1 M ammonium acetate, pH 7.0. A sample (10 μl) of the resuspended sediment was deposited on carbon-coated Formvar films, stained with 2% uranyl acetate and examined in the transmission electron microscope (TEM) JEM-100C (JEOL LTD, Tokyo, Japan) at 80 kV with magnification of 66 000×. The phage size was determined from the average of 5–7 independent measurements using T4 phage tail (114 nm) as the magnification control.
Determination of phage host range
The strains used in this study are listed in Table 2. Bacteria were stored at −70°C in Tryptone Soy Broth (TSB; Becton Dickinson and Company, Cockeysville, MD) supplemented with 20% glycerol. Prior to phage sensitivity testing bacteria were subcultured in TSB. For all phage experiments 4–6 h bacterial growth, unless otherwise stated, was used. To determine bacterial susceptibility to phage-mediated lysis, bacteria grown on liquid MHB medium were transferred directly onto MHA agar plates (bioMérieux). After drying, a drop of the phage suspension (108 PFU/ml) was put on the bacterial layer and incubated at 37°C. The plates were checked 4–6 h and again 18 h later for the presence of bacterial lysis. Spot testing is the rapid and efficient method for determining the host range in large collection of bacteria .
Phage adsorption procedure
The adsorption of phages to bacterial host cells was examined using a slight modification of previously described methods [45, 47]. Cells from an overnight culture plate (MHA) were suspended in MHB to OD600 ~0.9-1.0. An equal volume of bacterial suspension and phage diluted to 105-106 PFU/ml (MOI 0.001) were incubated at 37°C for 5 min. After incubation the culture was filtered (0.22 μm) and the free phages enumerated, in triplicate, in the filtrate using the double-agar-layer method. The reduction in phage titre was the number of phages adsorbed to the cells. No reduction in phage titre in control filtration (0.22 μm Millex-GP filters) was observed.
Burst size experiments
A one-step growth curve of isolated Klebsiella phages was performed according to the method of Pajunen et al. with modifications. The density of a mid-exponential bacterial culture in MHB was adjusted to 2 × 108 CFU/ml. To 0.9 ml of this cell suspension was added 0.1 ml of bacteriophage in order to achieve a multiplicity of infection of 0.005. Phages were allowed to adsorb for 5 min at 37°C, after which time the mixture was diluted to 10-5 and samples, in triplicate, were taken at 5 min intervals for titration. Experiment was performed at three different times and, the values depict the mean of three observations ± standard deviation (SD).
Sensitivity of phage particles to temperature, chloroform and pH
An equal volume of filter-sterilized bacteriophage (107 PFU/ml) was mixed with chloroform and incubated for 2 h at room temperature with intermittent shaking. Further preparations of phages were incubated at pH 4, 5, 6 and 8 for 1 h at room temperature. A phage preparation was also incubated at 60°C for 10 min. After all these experiments the bacteriophage titre was assessed using the double agar layer technique .
Isolation and restriction digestion of phage DNA
The DNA of six bacteriophage isolates (KP15, KP16, KP27, KP32, KP34 and KP36) were extracted and purified from phage lysates using a QIAGEN® Lambda Midi Kit (QIAGEN Inc., Valencia, CA, USA) and following the manufacturer’s protocol. These preparations were digested with restriction endonucleases which differed in sensitivity to DNA methylation (EcoRV, EcoRI, HindIII, NsiI, NcoI, PaeI, DpnI, EcoRII, SnaBI) purchased from Fermentas Life Science (Vilnius, Lithuania). The description of each restriction enzyme used in the study is presented in Table S1 (see Additional file 1: Table S1).
After the enzymatic digestion, the DNA fragments were separated by electrophoresis in a 0.6% agarose gel containing ethidium bromide (0.5 μg/ml) in Tris-boric acid-EDTA buffer, at 90 V in a Bio-Rad agarose gel electrophoresis system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). GeneRuler™ 1 kb Plus DNA Ladder (Fermentas Life Science) was used as a size marker. Restriction digestions were carried out in triplicate. The restriction patterns were compared with in silico genome digestion done with Webcutter 2.0 (http://rna.lundberg.gu.se/cutter2/).
This study was supported by Polish Ministry of Science and Higher Education research grant No. N N401 3550 33 and within the European Union project Operational Programme Innovative Economy 2007–2013 (OP IE) No POIG.01.03.01-02-003/08: “Optimization of the characteristics and production of therapeutic bacteriophages”. These funding bodies did not have any role in the design of the experiments, in the collection, analysis, and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.
- Abedon ST: Bacteriophage ecology. In Population growth, evolution, and impact of bacterial viruses. 1st edition. Edited by: Abedon ST. Cambridge, UK: Cambridge University Press; 2008.View Article
- Hemminga MA, Vos WL, Nazarov PV, Koehorst RB, Wolfs CJ, Spruijt RB, Stopar D: Viruses: incredible nanomachines. New advances with filamentous phages. Eur Biophys J 2010, 39:541–550.PubMedView Article
- Łusiak-Szelachowska M, Weber-Dąbrowska B, Górski A: The presence of bacteriophages in human feces and their potential importance. Pol Merkur Lekarski 2006, 21:381–383.PubMed
- Clokie MR, Millard AD, Letarov AV, Heaphy S: Phages in nature. Bacteriophage 2011, 1:31–45.PubMedView Article
- Chibani-Chennoufi S, Bruttin A, Dillmann ML, Brüssow H: Phage-host interaction: an ecological perspective. J Bacteriol 2004, 186:3677–3686.PubMedView Article
- Shapiro OH, Kushmaro A: Bacteriophage ecology in environmental biotechnology processes. Curr Opin Biotechnol 2011, 22:449–455.PubMedView Article
- Zaleski P, Wojciechowski M, Piekarowicz A: The role of Dam methylation in phase variation of haemophilus influenzae genes involved in defence against phage infection. Microbiology 2005, 151:3361–3369.PubMedView Article
- Kropinski AM: Measurement of the bacteriophage inactivation kinetics with purified receptors. Methods Mol Biol 2009, 501:157–160.PubMedView Article
- Withey S, Cartmell E, Avery LM, Stephenson T: Bacteriophages – potential for application in wastewater treatment processes. Sci Total Environ 2005, 339:1–18.PubMedView Article
- Donlan RM: Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 2009, 17:66–72.PubMedView Article
- Weinbauer MG: Ecology of prokaryotic viruses. FEMS Microbiol Rev 2004, 28:127–181.PubMedView Article
- Stern A, Sorek R: The phage-host arms race: shaping the evolution of microbes. Bioessays 2011, 33:43–51.PubMedView Article
- Bickle TA, Krüger DH: Biology of DNA restriction. Microbiol Rev 1993, 57:434–450.PubMed
- Labrie SJ, Samson JE, Moineau S: Bacteriophage Resistance mechanisms. Nat Rev Microbiol 2010, 8:317–327.PubMedView Article
- Warren RAJ: Modified bases in bacteriophage DNAs. Annu Rev Microbiol 1980, 34:137–158.PubMedView Article
- Kutateladze M, Adamia R: Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol 2010, 28:591–595.PubMedView Article
- European antimicrobial Resistance surveillance network. http://ecdc.europa.eu/en/activities/surveillance/EARS-Net/database/Pages/database.aspx
- Pappas G: An animal farm called extended-spectrum beta-lactamase: antimicrobial resistance as a zoonosis. Clin Microbiol Infect 2011, 17:797–798.PubMedView Article
- Carattoli A: Animal reservoirs for extended spectrum beta-lactamase producers. Clin Microbiol Infect 2008,14(Suppl 1):117–123. Erratum in: Clin Microbiol Infect 2008, 14 (Suppl 5):21–24PubMedView Article
- Warren RE, Ensor VM, O’Neill P, Butler V, Taylor J, Nye K, Harvey M, Livermore DM, Woodford N, Hawkey PM: Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2008, 61:504–508.PubMedView Article
- Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, Voets GM, van den Munckhof MP, van Essen-Zandbergen A, Platteel T, Fluit AC, van de Sande-Bruinsma N, Scharinga J, Bonten MJ, Mevius DJ, National ESBL surveillance group: Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011, 17:873–880.PubMedView Article
- Kropinski AM, Prangishvili D, Lavigne R: Position paper: the creation of a rational scheme for the nomenclature of viruses of bacteria and archaea . Environ Microbiol 2009, 11:2775–2777.PubMedView Article
- Ackermann HW: Classification of bacteriophages. In The bacteriophages. 2nd edition. Edited by: Calendar R. New York: Oxford University Press; 2006:8–16.
- Mehling JS, Lavender H, Clegg S: A Dam methylation mutant of Klebsiella pneumoniae is partially attenuated. FEMS Microbiol Lett 2007, 268:187–193.PubMedView Article
- Römling U, Grothues D, Bautsch W, Tümmler B: A physical genome map of pseudomonas aeruginosa PAO. EMBO J 1989, 8:4081–4089.PubMed
- Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, Zhao H, Gao Y, Song J, Lu R, Sun C, Feng X: A method for generation phage cocktail with great therapeutic potential. PLoS One 2012, 7:e31698.PubMedView Article
- Kumari S, Harjai K, Chhibber S: Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples. Folia Microbiol (Praha) 2010, 55:221–227.View Article
- Šimoliūnas E, Kaliniene L, Truncaite L, Klausa V, Zajančkauskaite A, Meškys R: Genome of klebsiella sp.-infecting bacteriophage vB_KleM_RaK2. J Virol 2012, 86:5406.PubMedView Article
- Verma V, Harjai K, Chhibber S: Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent. Curr Microbiol 2009, 59:274–281.PubMedView Article
- Wu LT, Chang SY, Yen MR, Yang TC, Tseng YH: Characterization of extended-host-range pseudo-T-even bacteriophage Kpp95 isolated on Klebsiella pneumoniae . Appl Environ Microbiol 2007, 73:2532–2540.PubMedView Article
- Hughes KA, Sutherland IW, Clark J, Jones MV: Bacteriophage and associated polysaccharide depolymerases – novel tools for study of bacterial biofilms. J Appl Microbiol 1998, 85:583–590. Erratum in: J Appl Microbiol 1999, 86(2):359PubMedView Article
- Hausmann R, Gold M: The enzymatic methylation of ribonucleic acid and deoxyribonucleic acid. IX. Deoxyribonucleic acid methylase in bacteriophage-infected Escherichia coli . J Biol Chem 1966, 241:1985–1994.PubMed
- Auer B, Schweiger M: Evidence that Escherichia coli virus T1 induces a DNA methyltransferase. J Virol 1984, 49:588–590.PubMed
- Wagner EF, Auer B, Schweiger M: Development of Escherichia coli virus T1: escape from host restriction. J Virol 1979, 29:1229–1231.PubMed
- Hung CH, Kuo CF, Wang CH, Wu CM, Tsao N: Experimental phage therapy in treating Klebsiella pneumoniae -mediated liver abscesses and bacteremia in mice. Antimicrob Agents Chemother 2011, 55:1358–1365.PubMedView Article
- Karamoddini MK, Fazli-Bazzaz BS, Emamipour F, Ghannad MS, Jahanshahi AR, Saed N, Sahebkar A: Antibacterial efficacy of lytic bacteriophages against antibiotic-resistant Klebsiella species. ScientificWorldJournal 2011, 11:1332–1340.PubMedView Article
- Kumari S, Harjai K, Chhibber S: Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae . J Microbiol Biotechnol 2009, 19:622–628.PubMed
- Kumari S, Harjai K, Chhibber S: Evidence to support the therapeutic potential of bacteriophage Kpn5 in burn wound infection caused by Klebsiella pneumoniae in BALB/c mice. J Microbiol Biotechnol 2010, 20:935–941.PubMedView Article
- Kumari S, Harjai K, Chhibber S: Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J Med Microbiol 2011, 60:205–210.PubMedView Article
- Gill JJ, Hyman P: Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol 2010, 11:2–14.PubMedView Article
- Jończyk E, Kłak M, Międzybrodzki R, Górski A: The influence of external factors on bacteriophages – review. Folia Microbiol (Praha) 2011, 56:191–200.View Article
- Ryan EM, Gorman SP, Donnelly RF, Gilmore BF: Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. J Pharm Pharmacol 2011, 63:1253–1264.PubMedView Article
- Leclerc H, Edberg S, Pierzo V, Delattre JM: Bacteriophages as indicators of enteric viruses and public health risk in groundwaters. J Appl Microbiol 2000, 88:5–21.PubMedView Article
- Adams MH: Bacteriophages. New York: Interscience Publishers, Inc.; 1959.
- Ślopek S, Durlakowa I, Kucharewicz-Krukowska A, Krzywy T, Ślopek A, Weber B: Phage typing of shigella flexneri . Arch Immunol Ther Exp (Warsz) 1972, 20:1–60.
- Kutter E: Phage host range and efficiency of plating. In Bacteriophages: methods And protocols. Volume 1: isolation, characterization, and interactions. 1st edition. Edited by: Clokie MRJ, Kropinski AM. New York: Humana Press; 2009:141–149.
- Gallet R, Shao Y, Wang IN: High adsorption rate is detrimental to bacteriophage fitness in a Biofilm-like environment. BMC Evol Biol 2009, 9:241–253.PubMedView Article
- Pajunen M, Kiljunen S, Skurnik M: Bacteriophage φYeO3–12, specific for yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. J Bacteriol 2000, 182:5114–5120.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.